首页 | 本学科首页   官方微博 | 高级检索  
检索        

缺血性卒中二级预防中的抗血小板治疗
引用本文:周志明.缺血性卒中二级预防中的抗血小板治疗[J].国外医学:脑血管疾病分册,2005,13(12):915-918.
作者姓名:周志明
作者单位:皖南医学院附属第二医院神经内科,芜湖241000
摘    要:抗血小板治疗是缺血性卒中二级预防的重要措施之一。在缺血性卒中二级预防中,阿司匹林仍然是最常用的抗血小板药。氯吡格雷的疗效优于阿司匹林,但因其价格昂贵,目前仅在阿司匹林不能耐受或阿司匹林无效者中使用。联合用药只推荐缓释型双嘧达莫加小剂量阿司匹林。

关 键 词:缺血性卒中  抗血小板药物  阿司匹林  氯吡格雷  双嘧达莫
收稿时间:2005-09-28
修稿时间:2005-10-25

Antiplatelet 1herapy in the Secondary Prevention of Ischemic Stroke
Zhi-Ming Zhou.Antiplatelet 1herapy in the Secondary Prevention of Ischemic Stroke[J].Foreign Medical Sciences Cerebrovascular Diseases,2005,13(12):915-918.
Authors:Zhi-Ming Zhou
Institution:Department of Neurology, the Second Affiliated Hospital of Wannan Medical College, Wuhu 241000, China
Abstract:Antiplatelet therapy is one of the important measures in the secondary prevention of ischemic stroke, Aspirin is still the most popular antiplatelet drug. The efficacy of clopidogrel is better than aspirin, but because its price is much expensive, now it is only used in patients who cannot tolerate aspirin or no response to it. The combination of sustained-release dipyridamole plus low dose aspirin is only recommended combination therapy.
Keywords:ischemic stroke antiplatelet drug aspirin clopidogrel dipyridamole
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号